VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $926,000 | -4.6% | 84,967 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $971,000 | -31.9% | 85,863 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $1,425,000 | +3.6% | 90,820 | +13.1% | 0.00% | 0.0% |
| Q3 2021 | $1,376,000 | -41.8% | 80,295 | -37.6% | 0.00% | -80.0% |
| Q1 2019 | $2,366,000 | -14.5% | 128,598 | +21.5% | 0.01% | -28.6% |
| Q4 2018 | $2,766,000 | +120.9% | 105,874 | +51.4% | 0.01% | +133.3% |
| Q3 2017 | $1,252,000 | +10.1% | 69,942 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $1,137,000 | – | 69,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |